Skip to main content
Earnings Labs
Structure Therapeutics Inc. logo

Structure Therapeutics Inc. (GPCR)

NASDAQ·Healthcare·Biotechnology

$35.66

-3.52%

Mkt Cap $3.25B

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (17 analysts)

$108.67

Range $70.00$145.00

Implied Upside

+204.7%

Consensus $108.67 vs current $35.66